Devyser signs first commercial reagent rental agreement under Illumina collaboration in Italy
Devyser, a global leader in advanced molecular diagnostics, today announced the first commercial...
News | September 15, 2019
Cancer is overtaking heart disease as the leading cause of death, according to a study published recently in The Lancet medical journal.
While heart disease remains the overall leading cause globally, the study of nearly 156k participants, across 21 countries over 11 years, has identified a trend that as living conditions improve, cancer begins to overtake heart disease. In middle-income countries cancer approaches the same rate, while in high-income countries it represents more than double the deaths of heart disease. These two diseases alone account for nearly 80% of deaths in middle-aged adults.
Devyser, a global leader in advanced molecular diagnostics, today announced the first commercial...
Read More
One Lambda™ Devyser Chimerism Plus is a next generation solution for chimerism analysis following...
Read More
Devyser, a leading provider of advanced genetic testing solutions, has been awarded a tender in...
Read More
Devyser, today announced the launch of Devyser Thalassemia v2, the first Next-Generation Sequencing...
Read More